Lymphact Overview
- Founded
- 2013
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
Lymphact General Information
Description
Provider of personalized medical treatments designed to focus on the treatment of cancer. The company's offers treatments through a technology platform that can generate autologous and allogeneic cellular immune therapies to target not only cancer and virus-infected cells, but also chemotherapy-resistant cancer stem cells and viral reservoirs for clinical applications, thereby enabling patients to get rid of chronic viral diseases quickly and painlessly.
Contact Information
Primary Office
- Zona Industrial De Cantanhede
- Coimbra, 3060-197
- Portugal
Lymphact Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 30-May-2018 | 000.00 | Completed | Startup | ||
| 3. Accelerator/Incubator | 000.00 | Completed | Startup | |||
| 2. Accelerator/Incubator | 14-Sep-2013 | $57.9K | Completed | Startup | ||
| 1. Seed Round | 01-May-2013 | $57.9K | $57.9K | Completed | Startup |
Lymphact Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Biocant Park | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Bynd Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Lisbon Challenge | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| PME Investimentos | Investment Bank | Minority | 000 0000 | 000000 0 | |
| Portugal Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |